Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Acquisition May Speed PD Therapies to Meet Unmet Needs

    Acquisition May Speed PD Therapies to Meet Unmet Needs

    Biotech acquisition could help speed PD therapeutic development.
    Learn more

  • Parkinson's Protein Blasting Off to Space

    MJFF is partnering to send LRRK2 protein to the International Space Station to grow larger LRRK2 crystals, which can help develop therapies. Michael J. Fox shares a special message on this project.
    Learn more
  • Update on Alpha-synuclein Therapies in Clinical Trials

    Update on Alpha-synuclein Therapies in Clinical Trials

    Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.
    Learn more
  • MJFF Scientist Highlights Alpha-synuclein Research Progress in Nature Reviews Drug Discovery

    MJFF Scientist Highlights Alpha-synuclein Research Progress in Nature Reviews Drug Discovery

    MJFF scientist speaks to "Nature Reviews Drug Discovery" about alpha-synuclein research progress in Parkinson's disease.
    Learn more
  • New Tool May Help Researchers Predict Cognitive Decline with Parkinson's Disease

    New Tool May Help Researchers Predict Cognitive Decline with Parkinson's Disease

    Researchers have developed a tool to predict cognitive decline in PD for use in designing clinical studies. The team analyzed data from multiple studies including PPMI.
    Learn more
  • New Findings Add to Evidence of Immune System Role in Parkinson's Disease

    New Findings Add to Evidence of Immune System Role in Parkinson's Disease

    MJFF-funded researchers published on a connection between the key Parkinson's protein alpha-synuclein and the immune system. This finding may point to a new way to stop or slow disease.
    Learn more
  • Getting Precise about Precision Medicine in Parkinson's

    Getting Precise about Precision Medicine in Parkinson's

    Prescribing therapies based on one’s genes, environment and/or lifestyle – rather than a one-size-fits-all approach – can help people find treatments that work for them.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.